ライフサイエンスコーパス: red cell transfusion

1 cause of transfusion-related mortality with red cell transfusion.

2 RDS risk and mortality including the role of red cell transfusion.

3 d significantly higher rates of bleeding and red-cell transfusion.

4 as the percentage of patients who received a red-cell transfusion.

5 o, 1.91; 95% confidence interval, 1.49-2.44) red cell transfusions.

6 er entry effectively decreased inappropriate red cell transfusions.

7 nd early death in patients receiving regular red cell transfusions.

8 ents, spleen response, and independence from red-cell transfusions.

9 tin (epoetin alfa) might reduce the need for red-cell transfusions.

10 ive vasopressor infusions (66.6% vs. 57.8%), red-cell transfusions (13.6% vs. 7.0%), and dobutamine (

11 e standard, autologous, leukoreduced, packed red cell transfusion after 1, 2, 3, 4, 5, or 6 weeks of

12 poetin alfa does not reduce the incidence of red-cell transfusion among critically ill patients, but

13 l failure have greatly reduced the number of red cell transfusions and hence the propensity to iron o

14 o identify patients who are at high risk for red cell transfusions and therefore most likely to benef

15 Secondary outcomes included red-cell transfusion and other clinical outcomes.

16 ter); 3 of them were previously dependent on red-cell transfusions and no longer needed transfusions.

17 of intravenous fluids, vasoactive drugs, and red-cell transfusions and reflected by significantly wor

18 Red cell transfusions are associated with the developmen

19 estrictive threshold for hemoglobin level in red-cell transfusions, as compared with a liberal thresh

20 nces in the proportion of patients requiring red cell transfusions, changes in quality of life, or th

21 A-DR15, younger age, and shorter duration of red cell transfusion dependence as pretreatment variable

22 ent revision include stricter definitions of red cell transfusion dependency and independency and con

23 We examined data from patients given red-cell transfusions during coronary-artery bypass graf

24 Jakob disease have been identified following red cell transfusions from donors who subsequently devel

25 ty and compliance with each of inotropes and red cell transfusions, glucocorticoids, and lung-protect

26 Whereas restrictive red cell transfusion has become a standard of care for t

27 ped an evidence-based decision algorithm for red cell transfusion in adult intensive care units.

28 esearch has focused on controlled studies of red cell transfusion in specific clinical settings.

29 otocol and computerized decision support for red cell transfusion in the critically ill.

30 ique, reduces the requirement for allogeneic red cell transfusions in patients undergoing major hepat

31 iology of SCD is better understood; however, red cell transfusion is currently the most studied and a

32 Restrictive red cell transfusion is recommended to minimize risk ass

33 hemoglobin threshold at which postoperative red-cell transfusion is warranted is controversial.

34 Red-cell transfusion occurred in 52.3% of the patients i

35 was associated with decreased likelihood of red cell transfusion (odds ratio, 0.43; 95% confidence i

36 01) and platelet (P =.01) recovery and fewer red cell transfusions (P =.02) than 48 historical contro

37 The mean number of red cell transfusions per intensive care unit admission

38 Although restrictive red cell transfusion practice has become a standard of c

39 =800 mL, ANH reduced not only the allogeneic red cell transfusion rate (18.2% vs. 42.4%, P = 0.045) b

40 ANH reduced the overall allogeneic red cell transfusion rate by 50% compared with STD.

41 reutzfeldt-Jakob disease and an asymptomatic red cell transfusion recipient, who did not die of varia

42 either the number of patients who received a red-cell transfusion (relative risk for the epoetin alfa

43 tients who received G-CSF + EPO had a higher red cell transfusion requirement (median, 161.0 mL/kg) t

44 rfarin resulted in faster reversal and lower red cell transfusion requirement with fewer adverse even

45 ary end point was the effect of EPO on total red cell transfusion requirements during induction thera

46 s, complexity of operation, or perioperative red cell transfusion requirements.

47 mpare outcomes of a restrictive to a liberal red cell transfusion strategy in 20% or more total body

48 The effect of a restrictive versus liberal red-cell transfusion strategy on clinical outcomes in pa

49 those in the G-CSF + EPO group received more red cell transfusions than did those given G-CSF alone (

50 eath after cardiac surgery) to a restrictive red-cell transfusion threshold (transfuse if hemoglobin

51 g from induction of anesthesia) or a liberal red-cell transfusion threshold (transfuse if hemoglobin

52 we randomly assigned patients who required a red-cell transfusion to receive blood that had been stor

53 Mean red cell transfusion was 3.2 with frozen plasma and 1.4

54 ovided to the 1098 participants who received red-cell transfusion was 7 days in the shorter-term stor

55 for death, a restrictive strategy regarding red-cell transfusion was noninferior to a liberal strate

56 verity of renal and hepatic dysfunction, and red cell transfusions were all independent risk factors

57 Red-cell transfusions were administered to 297 patients

58 in the critically ill, is often treated with red-cell transfusions, which are associated with poor cl

59 plasma hemoglobin increase immediately after red cell transfusion, with more significant increases ob